🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/10/2020 43,12 45,44 42,97 44,76 +3,95% 5,73% 1.004.700
30/09/2020 43,64 44,36 42,65 43,06 -0,83% 3,92% 908.900
29/09/2020 43,61 44,29 43,22 43,42 -0,60% 2,45% 818.900
28/09/2020 45,17 45,17 42,40 43,68 -2,75% 6,13% 1.080.300
25/09/2020 43,98 45,10 43,65 44,92 +1,37% 3,30% 847.400
24/09/2020 44,17 45,73 42,99 44,31 -0,74% 6,20% 858.900
23/09/2020 43,51 45,82 43,28 44,64 +1,92% 5,83% 1.740.100
22/09/2020 42,25 44,10 41,60 43,80 +5,01% 5,92% 1.503.500
21/09/2020 41,67 43,56 41,26 41,71 -3,23% 5,52% 1.295.100
18/09/2020 46,47 46,49 41,76 43,10 -5,79% 10,18% 4.042.100
17/09/2020 46,36 48,95 45,55 45,75 -3,54% 7,33% 2.649.900
16/09/2020 40,05 53,12 40,05 47,43 +40,33% 32,63% 23.998.700
15/09/2020 34,48 34,96 33,61 33,80 -0,71% 3,92% 1.034.400
14/09/2020 33,86 34,68 33,22 34,04 +2,50% 4,31% 1.363.700
11/09/2020 35,53 35,66 32,86 33,21 -5,65% 7,88% 1.904.100
10/09/2020 36,32 37,81 34,90 35,20 -2,60% 8,00% 1.269.300
09/09/2020 35,77 36,71 35,21 36,14 +1,89% 4,19% 806.600
08/09/2020 35,25 36,80 34,55 35,47 -1,58% 6,38% 1.062.100
04/09/2020 37,50 37,98 34,00 36,04 -2,75% 10,61% 1.201.700
03/09/2020 39,50 39,61 36,75 37,06 -6,95% 7,23% 1.060.900
02/09/2020 39,01 40,06 37,66 39,83 +2,13% 6,16% 1.041.300
01/09/2020 41,88 42,74 38,89 39,00 -7,67% 9,19% 1.494.400
31/08/2020 42,58 43,64 42,05 42,24 +0,64% 3,73% 921.900
28/08/2020 42,00 43,01 41,52 41,97 +0,31% 3,55% 665.300
27/08/2020 42,62 42,67 40,33 41,84 -1,25% 5,49% 777.000
26/08/2020 43,24 43,83 42,23 42,37 -2,22% 3,70% 529.800
25/08/2020 42,74 43,63 42,17 43,33 +1,10% 3,43% 452.400
24/08/2020 43,33 43,37 41,52 42,86 +0,87% 4,26% 741.200
21/08/2020 42,80 43,31 42,09 42,49 -1,32% 2,87% 696.700
20/08/2020 44,44 44,80 41,98 43,06 -4,25% 6,35% 967.400